Berlin, Germany

Claus S Sturzebecher

This inventor holds 2 USPTO granted patents. Top assignee: Schering Aktiengesellschaft. Active years: 1993-1994.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Claus S Sturzebecher. Retrieved from https://idiyas.com/inventor/claus-s-sturzebecher

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 12(Granted Patents)


Company Filing History:


Years Active: 1993-1994

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Claus S Sturzebecher: Innovator in Prostaglandin Derivatives

Introduction

Claus S Sturzebecher is a notable inventor based in Berlin, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of prostaglandin derivatives. With a total of 2 patents, his work has had a meaningful impact on medical science.

Latest Patents

Sturzebecher's latest patents include innovations related to .DELTA.8- and .DELTA.9-prostaglandin derivatives. These inventions focus on the derivatives of formula I, which involve specific radicals and functional groups that enhance their pharmaceutical properties. His work in this area is crucial for advancing therapeutic applications.

Career Highlights

Throughout his career, Claus S Sturzebecher has worked with prominent companies, including Schering Aktiengesellschaft. His experience in the pharmaceutical industry has allowed him to develop groundbreaking inventions that contribute to medical advancements.

Collaborations

Sturzebecher has collaborated with esteemed colleagues such as Ulrich Klar and Hartmut Rehwinkel. These partnerships have fostered innovation and have been instrumental in the development of his patented technologies.

Conclusion

Claus S Sturzebecher is a distinguished inventor whose work in prostaglandin derivatives has paved the way for advancements in pharmaceuticals. His contributions continue to influence the field and highlight the importance of innovation in medicine.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…